Filter by category



Tissue Type






MTF Biologics’ Awarded Tissue Implantable Products and Bone and Bone Substitute Implantable Products Contracts with Premier, Inc.

MTF Biologics’ Awarded Tissue Implantable Products and Bone and Bone Substitute Implantable Products Contracts with Premier, Inc.


Kate Raley,




Edison, N.J. (May 27, 2021) – MTF Biologics, a global non-profit organization that saves and heals lives by honoring donated gifts, serving patients and advancing science, has been awarded a group purchasing agreement for Tissue Implantable Products and Bone and Bone Substitute Implantable Products with Premier, Inc. Effective July 1, 2021, the new agreement allows Premier members, access to MTF Biologics’ extensive portfolio of ortho biologics and soft tissue offerings.   


“MTF Biologics is proud to work with Premier by offering clinicians aseptically recovered and processed tissues preserving the biomechanical and biological integrity of the tissue” said Robert Mayes, Senior National Accounts Manager of MTF Biologics. MTF Biologics’ processing balances safety with quality by avoiding harsh chemicals and terminal radiation which lead to suboptimal clinical outcomes.”

MTF Biologics Orthopaedic Division offers a depth and breadth of allograft options unmatched in the industry.  For over 30 years, MTF Biologics has set itself apart with a dedication to advancing the science of transplantation and has given over $55 million towards science and clinical research. As a 501 (c) (3) non-profit, that was physician-founded in 1987, we have provided over 9 million allografts to facilities and physicians for transplantation from more than 148,000 donors. At MTF Biologics, we set stricter standards to ensure safety, quality, and better outcomes. Our non-profit organization is led by surgeons and our processes are approved and monitored by a medical board of trustees.

 “MTF Biologics provides one of the largest portfolios of orthopedic and sports medicine tissues in the industry from bone void fillers to spinal spacers to allograft tendons.” said Keith Morocko, Vice President of MTF Biologics Contract Administration. “We are excited to work with Premier to further our commitment to patients by providing innovative and lifesaving tissues to its extensive network of hospitals and clinicians across the nation.”


Premier is a leading healthcare improvement company, uniting an alliance of more than 4,100 U.S. hospitals and 200,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost.





About MTF Biologics

MTF Biologics is a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research.  We provide unmatched service, resources, and expertise to donors and their loved ones who give the gift of life, people who depend on tissue and organ transplants, healthcare providers, and clinicians and scientists.  Our subsidiary, The International Institute for the Advancement of Medicine (IIAM), honors donors of non-transplantable organs by providing their gifts to the medical research community to combat and cure diseases.  Our subsidiary, Statline, provides specialized communications and technology expertise to organ, tissue, and eye procurement organizations, as well as the hospitals and patients that they serve.  Our sister organization, The German Institute for Cell and Tissue Transplantation (Deutsches Institute for Zell-und Gewebeersatz – DIZG) expands our reach to patients across the globe. For more information, visit